YiChang HEC ChangJiang Pharmaceutical Co., Ltd. (HKG:1558)

Market Cap	13.11B
Revenue (ttm)	3.96B
Net Income (ttm)	513.69M
Shares Out	879.97M
EPS (ttm)	0.58
PE Ratio	25.52
Forward PE	8.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,683,000
Average Volume	11,169,510
Open	14.98
Previous Close	15.00
Day's Range	14.64 - 15.18
52-Week Range	7.92 - 15.54
Beta	0.04
RSI	59.84
Earnings Date	May 30, 2025

About HKG:1558

YiChang HEC ChangJiang Pharmaceutical Co., Ltd. engages in the development, manufacturing, and sale of pharmaceutical products in the therapeutic areas of anti-virus, endocrine and metabolic, and cardiovascular diseases in the People’s Republic of China. It manufactures and sells active pharmaceutical ingredients and drugs; researches and develops pharmaceutical products and medical devices, as well as biotechnology; and provides marketing and medical consulting services. The company’s product portfolio includes Kewei, Oumeining, Xinhaining, Er...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 4,861
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1558

Financial Performance

In 2024, HKG:1558's revenue was 3.72 billion, a decrease of -40.84% compared to the previous year's 6.29 billion. Earnings were 482.71 million, a decrease of -75.78%.

Financial numbers in CNY